IONIS PHARMACEUTICALS 401(K) PLAN
ERISA Form 5500 plan record drawn from DOL EBSA — verify with linked source filings below.
IONIS PHARMACEUTICALS, INC.
This Profit Sharing plan holds $255M in total assets and serves 760 participants as of 2023. It is sponsored by IONIS PHARMACEUTICALS, INC. in California. The plan reported positive net income of $60M for the year.
What the Filing Says About IONIS PHARMACEUTICALS 401(K) PLAN
IONIS PHARMACEUTICALS 401(K) PLAN is a Profit Sharing retirement plan sponsored by IONIS PHARMACEUTICALS, INC., headquartered in California. As of the 2023 Form 5500 filing, the plan reports $255M in total end-of-year assets and covers 760 participants across the Professional & Technical Services industry. The sponsor's EIN on file with the U.S. Department of Labor is 330336973, and the plan has been effective since 1991-01-01. Its filing status is currently FILING RECEIVED.
Year over year, total assets moved from $195M at the beginning of 2023 to $255M at year-end — a gain of 30.6%. Net assets (after liabilities) closed the year at $255M, with reported net income of $60M driven by investment returns, contributions received, and benefit payments during the period. These figures reflect what the plan administrator certified on Schedule H or Schedule I of the Form 5500 annual return and can be compared against 2 prior plan-year filings from the same sponsor shown below.
Asset totals and participant counts reflect a single plan year snapshot and can change materially with market conditions, plan mergers, or workforce changes. Fields such as "net income" include both realized investment performance and contribution/distribution flows — a single-year figure does not by itself indicate plan health or participant outcomes. This page summarizes public DOL disclosures for research and educational purposes only and is not retirement, tax, legal, or financial advice. Before making decisions about your own retirement benefits or evaluating an employer's plan, verify the underlying filing directly via the DOL EFAST2 system and consult a qualified professional.
Financial Summary (2023)
| Total Assets (Beginning of Year) | $195M |
| Total Assets (End of Year) | $255M |
| Net Assets (End of Year) | $255M |
| Net Income | $60M |
| Plan Type | Profit Sharing |
| Employer EIN | 330336973 |
| Plan Effective Date | 1991-01-01 |
| Filing Status | FILING RECEIVED |
Sponsor Plan History (IONIS PHARMACEUTICALS, INC.)
| Year | Plans | Participants | Total Assets |
|---|---|---|---|
| 2022 | 1 | 609 | $195M |
| 2023 | 1 | 760 | $255M |
| 2024 | 1 | 897 | $316M |
Nearby Profit Sharing Plans in California
Peer Profit Sharing plans — same state, same plan type — ranked by total assets.
- STANFORD CONTRIBUTORY RETIREMENT PLAN $11.0B · 21,674
- SUTTER HEALTH 403(B) SAVINGS PLAN $6.5B · 50,273
- STANFORD HEALTH CARE RETIREMENT SAVINGS PLAN $5.8B · 22,681
- HONDA 401(K) SAVINGS PLAN $5.5B · 34,918
- CALTECH BASE RETIREMENT PLAN $4.8B · 10,682
Related Data
Guides
Frequently Asked Questions
How much money is in the IONIS PHARMACEUTICALS 401(K) PLAN? ▼
What type of plan is IONIS PHARMACEUTICALS 401(K) PLAN? ▼
Who sponsors the IONIS PHARMACEUTICALS 401(K) PLAN? ▼
How did IONIS PHARMACEUTICALS 401(K) PLAN perform in 2023? ▼
Where can I find official filings for IONIS PHARMACEUTICALS 401(K) PLAN? ▼
How does IONIS PHARMACEUTICALS 401(K) PLAN compare to other plans? ▼
Explore PlainRetire
Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2023.
Source: DOL EFAST2 filing system (efast.dol.gov) — original filing retrieval by EIN 330336973.
Reference: IRS Publication 560 — Retirement Plans for Small Business, contribution-limit rules.
Reference: IRS Publication 590-B — Distributions from IRAs, RMD rules under SECURE Act 2.0.
Read our methodology — how this data is sourced, computed, and verified.